Zheng Sarah, Ren Zhong Justin, Heineke Janelle, Geissler Kimberley H
*Department of Operations and Technology Management, Boston University Questrom School of Business, Boston ‡Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst †Massachusetts Institute of Technology (MIT) Sloan School of Management, Cambridge, MA.
Med Care. 2016 Feb;54(2):110-7. doi: 10.1097/MLR.0000000000000472.
Diagnostic imaging utilization grew rapidly over the past 2 decades. It remains unclear whether patient cost-sharing is an effective policy lever to reduce imaging utilization and spending.
Using 2010 commercial insurance claims data of >21 million individuals, we compared diagnostic imaging utilization and standardized payments between High Deductible Health Plan (HDHP) and non-HDHP enrollees. Negative binomial models were used to estimate associations between HDHP enrollment and utilization, and were repeated for standardized payments. A Hurdle model were used to estimate associations between HDHP enrollment and whether an enrollee had diagnostic imaging, and then the magnitude of associations for enrollees with imaging. Models with interaction terms were used to estimate associations between HDHP enrollment and imaging by risk score tercile. All models included controls for patient age, sex, geographic location, and health status.
HDHP enrollment was associated with a 7.5% decrease in the number of imaging studies and a 10.2% decrease in standardized imaging payments. HDHP enrollees were 1.8% points less likely to use imaging; once an enrollee had at least 1 imaging study, differences in utilization and associated payments were small. Associations between HDHP and utilization were largest in the lowest (least sick) risk score tercile.
Increased patient cost-sharing may contribute to reductions in diagnostic imaging utilization and spending. However, increased cost-sharing may not encourage patients to differentiate between high-value and low-value diagnostic imaging services; better patient awareness and education may be a crucial part of any reductions in diagnostic imaging utilization.
在过去20年中,诊断成像的使用迅速增加。患者成本分担是否是降低成像使用和支出的有效政策杠杆仍不清楚。
利用超过2100万个体的2010年商业保险理赔数据,我们比较了高免赔额健康计划(HDHP)和非HDHP参保者之间的诊断成像使用情况和标准化支付。使用负二项式模型估计HDHP参保与使用之间的关联,并对标准化支付重复进行。使用障碍模型估计HDHP参保与参保者是否进行诊断成像之间的关联,然后估计成像参保者的关联程度。使用带有交互项的模型估计HDHP参保与按风险评分三分位数划分的成像之间的关联。所有模型都包括对患者年龄、性别、地理位置和健康状况的控制。
HDHP参保与成像检查数量减少7.5%和标准化成像支付减少10.2%相关。HDHP参保者使用成像的可能性降低1.8个百分点;一旦参保者至少进行了1次成像检查,使用和相关支付的差异就很小。HDHP与使用之间的关联在最低(病情最轻)风险评分三分位数中最大。
增加患者成本分担可能有助于降低诊断成像的使用和支出。然而,增加成本分担可能不会鼓励患者区分高价值和低价值的诊断成像服务;提高患者的意识和教育可能是降低诊断成像使用的任何措施的关键部分。